Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 584

1.

Augmentation with citalopram for suicidal ideation in middle-aged and older outpatients with schizophrenia and schizoaffective disorder who have subthreshold depressive symptoms: a randomized controlled trial.

Zisook S, Kasckow JW, Lanouette NM, Golshan S, Fellows I, Vahia I, Mohamed S, Rao S.

J Clin Psychiatry. 2010 Jul;71(7):915-22. doi: 10.4088/JCP.09m05699gre. Epub 2010 Mar 9.

PMID:
20361918
2.

Citalopram augmentation for subsyndromal symptoms of depression in middle-aged and older outpatients with schizophrenia and schizoaffective disorder: a randomized controlled trial.

Zisook S, Kasckow JW, Golshan S, Fellows I, Solorzano E, Lehman D, Mohamed S, Jeste DV.

J Clin Psychiatry. 2009 Apr;70(4):562-71. Epub 2008 Dec 16.

PMID:
19192468
3.

Citalopram augmentation of antipsychotic treatment in older schizophrenia patients.

Kasckow JW, Mohamed S, Thallasinos A, Carroll B, Zisook S, Jeste DV.

Int J Geriatr Psychiatry. 2001 Dec;16(12):1163-7.

PMID:
11748776
4.

Response to intravenous antidepressant treatment by suicidal vs. nonsuicidal depressed patients.

Pompili M, Baldessarini RJ, Tondo L, Innamorati M, Tatarelli R, Girardi P, De Pisa E.

J Affect Disord. 2010 Apr;122(1-2):154-8. doi: 10.1016/j.jad.2009.07.018. Epub 2009 Aug 25.

PMID:
19709752
5.

Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor.

Lenox-Smith AJ, Jiang Q.

Int Clin Psychopharmacol. 2008 May;23(3):113-9. doi: 10.1097/YIC.0b013e3282f424c2.

PMID:
18408525
6.

Effect of antidepressant medication treatment on suicidal ideation and behavior in a randomized trial: an exploratory report from the Combining Medications to Enhance Depression Outcomes Study.

Zisook S, Lesser IM, Lebowitz B, Rush AJ, Kallenberg G, Wisniewski SR, Nierenberg AA, Fava M, Luther JF, Morris DW, Trivedi MH.

J Clin Psychiatry. 2011 Oct;72(10):1322-32. doi: 10.4088/JCP.10m06724.

PMID:
22075098
7.

A randomized controlled trial of duloxetine versus placebo in the treatment of nonmajor chronic depression.

Hellerstein DJ, Stewart JW, McGrath PJ, Deliyannides DA, Batchelder ST, Black SR, Withers A, O'Shea D, Chen Y.

J Clin Psychiatry. 2012 Jul;73(7):984-91. doi: 10.4088/JCP.11m07230.

PMID:
22901348
8.

A randomized, double-blind, placebo-controlled study of citalopram in adolescents with major depressive disorder.

von Knorring AL, Olsson GI, Thomsen PH, Lemming OM, Hultén A.

J Clin Psychopharmacol. 2006 Jun;26(3):311-5.

PMID:
16702897
9.

A randomized, placebo-controlled trial of citalopram for the prevention of major depression during treatment for head and neck cancer.

Lydiatt WM, Denman D, McNeilly DP, Puumula SE, Burke WJ.

Arch Otolaryngol Head Neck Surg. 2008 May;134(5):528-35. doi: 10.1001/archotol.134.5.528.

PMID:
18490576
10.

Association between treatment-emergent suicidal ideation with citalopram and polymorphisms near cyclic adenosine monophosphate response element binding protein in the STAR*D study.

Perlis RH, Purcell S, Fava M, Fagerness J, Rush AJ, Trivedi MH, Smoller JW.

Arch Gen Psychiatry. 2007 Jun;64(6):689-97.

PMID:
17548750
11.

Meta-analysis of efficacy and treatment-emergent suicidality in adults by psychiatric indication and age subgroup following initiation of paroxetine therapy: a complete set of randomized placebo-controlled trials.

Carpenter DJ, Fong R, Kraus JE, Davies JT, Moore C, Thase ME.

J Clin Psychiatry. 2011 Nov;72(11):1503-14. doi: 10.4088/JCP.08m04927blu. Epub 2011 Feb 22.

PMID:
21367354
12.

A double-blind, placebo-controlled treatment trial of citalopram for major depressive disorder in older patients with heart failure: the relevance of the placebo effect and psychological symptoms.

Fraguas R, da Silva Telles RM, Alves TC, Andrei AM, Rays J, Iosifescu DV, Wajngarten M.

Contemp Clin Trials. 2009 May;30(3):205-11. doi: 10.1016/j.cct.2009.01.007. Epub 2009 Jan 24.

PMID:
19470312
14.

Fluoxetine and suicide: a meta-analysis of controlled trials of treatment for depression.

Beasley CM Jr, Dornseif BE, Bosomworth JC, Sayler ME, Rampey AH Jr, Heiligenstein JH, Thompson VL, Murphy DJ, Masica DN.

BMJ. 1991 Sep 21;303(6804):685-92. Erratum in: BMJ 1991 Oct 19;303(6808):968.

15.
16.
17.
18.

Can we really accelerate and enhance the selective serotonin reuptake inhibitor antidepressant effect? A randomized clinical trial and a meta-analysis of pindolol in nonresistant depression.

Portella MJ, de Diego-Adeliño J, Ballesteros J, Puigdemont D, Oller S, Santos B, Álvarez E, Artigas F, Pérez V.

J Clin Psychiatry. 2011 Jul;72(7):962-9. doi: 10.4088/JCP.09m05827blu. Epub 2010 Oct 19.

PMID:
21034693
19.

A randomized controlled trial of antidepressant continuation for major depression following traumatic brain injury.

Rapoport MJ, Mitchell RA, McCullagh S, Herrmann N, Chan F, Kiss A, Feinstein A, Lanctôt KL.

J Clin Psychiatry. 2010 Sep;71(9):1125-30. doi: 10.4088/JCP.09m05086blu. Epub 2010 Apr 20.

PMID:
20441723
20.

Quetiapine as combination treatment with citalopram in unipolar depression with prominent somatic symptoms: a randomised, double-blind, placebo-controlled pilot study.

Quante A, Regen F, Schindler F, Volkmer K, Severus E, Urbanek C, Luborzewski A, Roepke S, Anghelescu I.

Psychiatr Danub. 2013 Sep;25(3):214-20.

Supplemental Content

Support Center